# A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)

> **NCT02831634** · NA · COMPLETED · sponsor: **Institut Curie** · enrollment: 25 (actual)

## Conditions studied

- Breast Cancer
- Cutaneous Melanoma

## Interventions

- **PROCEDURE:** Blood sampling

## Key facts

- **NCT ID:** NCT02831634
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-09
- **Primary completion:** 2018-03-01
- **Final completion:** 2018-03-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02831634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02831634, "A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02831634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*